European countries separated themselves from the US about Covid-19 vaccine waivers. French leader Macron said that IP rights is not the issue of the day. All the leaders of 27-nation bloc discussed the proposal of the US to share vaccine IP rights. But EU leaders were divided on its usefulness. According to experts, waiver negotiation will take years and cannot be covered for immediate needs.